Sarepta Therapeutics (SRPT) Asset Utilization Ratio (2013 - 2026)

Sarepta Therapeutics' Asset Utilization Ratio history runs 12 years deep, the most recent figure standing at 0.57 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 30.05% year-over-year to 0.57; the TTM figure through Mar 2026 stood at 0.57 (up 30.05% YoY), while the FY2025 annual figure was 0.6, up 14.23% from the prior year.
• Asset Utilization Ratio was 0.57 for Q1 2026 at Sarepta Therapeutics, up from 0.46 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.57 in Q1 2026 to a low of 0.15 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.36 across 5 years, with a median of 0.38 in 2024.
• The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio surged 124.04% in 2024, then dropped 7.8% in 2025.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.19 in 2022, then surged by 73.07% to 0.34 in 2023, then jumped by 49.66% to 0.5 in 2024, then decreased by 7.8% to 0.46 in 2025, then climbed by 22.45% to 0.57 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.57 (Q1 2026), 0.46 (Q4 2025), and 0.5 (Q3 2025), per Business Quant data.